Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3013336	p-aminoh	— (—)	193	511	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Mental retardation, excluding more controls

14.75

35.97

1.6

3.6

—

Care involving use of rehabilitation procedures

5.65

30.55

3.1

2.1

—

Metabolic disorders

4.92

25.88

4.7

1.7

—

Intestinal infectious diseases

112

4.51

25.70

2.8

2.2

—

Procreative management

5.37

25.67

3.3

2.6

—

Nausea and vomiting

5.86

24.97

3.4

1.9

—

Persons encountering health services for specific procedures and health care

110

4.02

22.63

2.7

2.3

—

Diarrhoea and gastroenteritis of presumed infectious origin

111

4.51

22.56

2.8

2.2

—

Any mental disorder

5.90

22.00

2.7

3.1

—

Symptoms and signs involving the nervous and musculoskeletal systems

4.90

21.70

1.9

2.3

—

Speech and linguistic disorders, excluding more controls

8.29

21.53

1.8

3.4

—

Disorders of other endocrine glands

114

4.24

18.88

3.0

2.5

—

Endocrine, nutritional and metabolic diseases

4.51

18.72

2.7

1.7

—

Mental retardation, wide definition

5.43

17.89

1.5

2.7

—

Mental retardation

5.43

17.88

1.5

2.7

—

Malaise and fatigue

5.74

17.58

2.3

2.5

—

Diseases of the digestive system

5.19

17.25

3.4

2.4

—

Mixed specific developmental disorders

6.19

16.96

2.7

2.8

—

Implicit viral Sepsis, including avohilmo

6.58

16.94

4.5

1.9

—

Implicit Sepsis

4.76

16.92

3.6

1.9

—

Disorders of psychological development

4.78

16.66

1.9

2.9

—

Anxiety disorders, excluding more controls

6.39

16.64

2.4

3.6

—

Other symptoms and signs involving the nervous and musculoskeletal systems

5.24

16.50

2.2

2.1

—

Specific developmental disorder of motor function

6.99

16.05

3.5

2.5

—

Implicit bacterial Sepsis

7.89

15.80

2.8

2.2

—

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

4.10

15.21

3.1

2.6

—

Hyperkinetic disorders, excluding more controls

7.17

15.15

2.7

3.2

—

Medical observation and evaluation for suspected diseases and conditions

6.82

15.14

2.6

2.2

—

Viral and other specified intestinal infections

4.68

14.84

4.6

2.1

—

Psychiatric diseases

4.89

14.78

2.8

3.1

—

Implicit bacterial Sepsis, including avohilmo

7.36

14.75

2.8

2.2

—

Intestinal stricture

14.14

14.49

3.4

3.2

—

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

3.81

14.36

3.4

2.2

—

Bacterial Sepsis

6.46

14.32

2.8

2.0

—

Speech and linguistic disorders

4.09

14.25

1.8

3.2

—

Implicit Sepsis, including avohilmo

4.11

14.12

3.6

1.8

—

Viral and other specified intestinal infections, including avohilmo

4.28

14.05

4.4

2.0

—

Other endocrine disorders

4.22

14.01

2.5

—

Anaemias

5.17

13.73

3.4

2.4

—

Lack of expected normal physiological development

5.67

13.28

3.5

2.0

—

Condition for Implicit Sepsis (Organ dysfunction codes)

3.72

12.62

3.6

1.8

—

Motor disorders, excluding more controls

10.59

12.55

3.6

2.5

—

Other disorders of glucose regulation and pancreatic internal secretion

11.01

12.50

1.6

3.5

—

Other problems related to primary support group, including family circumstances

3.95

12.00

3.3

2.7

—

Somatoform disorder

21.29

11.99

1.6

4.1

—

Implicit viral Sepsis

8.64

11.97

4.8

2.0

—

Viral Sepsis

8.64

11.97

4.8

2.0

—

Other disorders of fluid, electrolyte and acid-base balance

13.46

11.80

6.3

2.4

—

Short stature, not elsewhere classified

4.08

11.74

2.4

2.3

—

Complications of surgical and medical care, not elsewhere classified

4.17

11.73

3.3

2.1

—

Disorders of ocular muscles, binocular movement, accommodation and refraction

127

3.28

11.39

1.8

3.0

—

Congenital malformations, deformations and chromosomal abnormalities

103

3.50

11.25

2.6

2.4

—

Neurotic, stress-related and somatoform disorders

3.69

11.02

2.2

3.5

—

Delayed milestone in childhood

3.94

11.00

2.9

2.4

—

Anxiety disorders

3.67

10.95

2.2

3.5

—

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

104

3.08

10.90

3.3

2.1

—

Complications of procedures, not elsewhere classified

4.91

10.85

3.5

2.3

—

General examination and investigation of persons without complaint and reported diagnosis

5.63

10.67

2.4

2.2

—

Complications of medical and surgical care

4.33

10.53

3.9

1.8

—

Other and unspecified mental retardation

4.89

10.41

1.2

2.8

—

Explicit Sepsis

4.11

10.28

3.3

2.2

—

Other functional intestinal disorders

109

3.25

10.24

2.2

2.4

—

Hypoglycaemia, other or unspecified

9.58

10.24

1.5

3.5

—

Exclusions for E4_PCOS_BROAD

4.01

10.18

4.0

2.2

—

Epilepsy

3.63

10.16

2.8

2.5

—

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

101

3.29

10.03

2.3

2.5

—

Specific development disorders of speech and language

4.65

9.93

2.1

3.4

—

Diseases of the myoneural junction and muscle

12.18

9.83

2.1

3.0

—

Motor disorders

4.34

9.82

3.5

2.1

—

Explicit Sepsis, including avohilmo

3.97

9.80

3.2

2.2

—

Any gastric operation

3.16

9.62

3.2

2.0

—

GASTRO-related operations

3.16

9.62

3.2

2.0

—

All influenza

4.29

9.56

6.2

1.8

—

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

122

2.74

9.49

3.0

2.2

—

Disorders of ornithine metabolism

+∞

9.34

8.3

0.0

—

Cerebral palsy and other paralytic syndromes

8.03

9.32

2.6

3.0

—

Persons encountering health services in circumstances related to reproduction

103

2.93

9.20

3.6

2.4

—

Exclusions for E4_PCOS_CONSORTIUM

3.05

9.19

4.0

2.5

—

Convulsions, not elsewhere classified

4.29

9.13

1.7

2.6

—

Pain, not elsewhere classified

7.01

8.99

2.0

2.4

—

Other or unspecified ileus, impaction or obstruction

18.59

8.92

2.9

4.0

—

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

105

3.12

8.91

2.6

2.4

—

Influenza and pneumonia

127

2.62

8.86

3.9

2.2

—

Mood disorders, excluding more controls

4.70

8.81

2.9

3.7

—

Examination and observation for other reasons

5.17

8.72

2.5

2.2

—

Other disorders starting during childhood or adolecense, excluding more controls

6.72

8.67

4.0

3.2

—

All anxiety disorders

3.63

8.62

2.4

3.0

—

Pneumonia, organism unspecified

118

2.73

8.58

3.0

2.2

—

Paralytic ileus and intestinal obstruction

11.54

8.55

2.7

3.1

—

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

4.46

8.32

3.6

1.8

—

All pneumoniae

132

2.56

8.28

3.8

2.3

—

Symptoms and signs involving cognition, perception, emotional state and behaviour

3.09

8.28

1.7

3.0

—

Persons encountering health services in other circumstances, wide

2.67

8.23

2.4

2.7

—

Anxiety (asthma-related co-morbidities)

3.55

8.03

2.5

2.8

—

Fever of other and unknown origin

3.63

8.01

3.3

2.5

—

Other reaction to severe stress, and adjustment disorders

6.25

7.98

2.3

3.3

—

Other septicaemia

3.87

7.93

3.6

2.3

—

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

125

2.59

7.91

2.9

2.6

—

Nutritional anaemias

3.85

7.88

2.8

3.1

—

Other septicaemia, including avohilmo

3.79

7.69

3.6

2.3

—

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

134

2.48

7.59

2.9

2.6

—

Other noninfective gastroenteritis and colitis

3.29

7.48

3.1

2.3

—

Iron deficiency anaemia

3.79

7.44

2.7

3.1

—

Disorders of refraction and accommodation

108

2.95

7.42

2.0

3.0

—

Pneumonias (Asthma/COPD co-morbidities)

133

2.45

7.38

2.9

2.6

—

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

3.73

7.33

4.7

2.3

—

Septicaemia

3.45

7.28

3.5

2.4

—

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

4.12

7.22

3.6

2.3

—

20.02

7.13

2.4

7.4

—

Hypopituitarism

6.03

7.06

5.6

2.5

—

Abnormal findings on examination of blood, without diagnosis

3.93

6.97

3.4

2.6

—

Other and unspecified anaemias

4.43

6.95

4.4

2.3

—

Other anaemias

4.42

6.92

4.4

2.3

—

Other respiratory disorders and diseases

7.51

6.88

3.5

1.7

—

Other diseases of the respiratory system

7.51

6.88

3.5

1.7

—

3.01

6.86

3.5

2.3

—

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

3.01

6.86

3.5

2.3

—

Other special examinations and investigations of persons without complaint or reported diagnosis

4.43

6.83

3.6

2.2

—

Myalgia

9.29

6.77

1.3

2.4

—

Intestinal infectious diseases, including avohilmo, including avohilmo

103

2.49

6.70

2.8

2.1

—

Other anxiety disorders

3.60

6.69

2.4

3.2

—

Aplastic and other anaemias

3.95

6.69

4.1

2.2

—

Dental caries

3.90

6.63

4.2

1.6

—

General symptoms and signs

2.81

6.52

2.3

2.5

—

Hypokalaemia

14.31

6.39

2.8

2.6

—

Other neurological diseases

3.62

6.27

2.4

2.3

—

KRA_PSY_EATING, excluding more controls

9.16

6.24

2.9

3.6

—

Specific development disorders of scholastic skills

5.07

6.20

1.4

4.0

—

Neurological diseases

2.41

6.11

2.5

2.6

—

Persons encountering health services for examination and investigation

4.18

6.09

3.5

2.2

—

Renal failure

4.02

6.01

4.7

2.4

—

Cerebral cysts

15.04

5.90

1.7

4.7

—

Other antidepressants

3.11

5.86

2.4

2.8

—

L04AA Selective immunosuppressants

3.78

5.80

3.9

2.5

—

Benzodiazepine use

2.91

5.78

3.0

3.1

—

Substance abuse, excluding more controls

8.35

5.76

2.7

3.2

—

Transplanted organ and tissue status

4.87

5.73

3.8

2.3

—

Emotional disorders starting during childhood or adolecense, excluding more controls

6.19

5.70

1.4

3.7

—

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

3.52

5.65

3.2

1.9

—

Wide developmental disorders, excluding more controls

5.98

5.58

1.8

3.0

—

Artificial opening status

8.50

5.55

2.2

—

Other metabolic disorders

10.01

5.52

1.8

2.3

—

Personality disorders, excluding more controls

9.98

5.51

1.4

3.4

—

Opioids

3.39

5.50

2.7

3.1

—

Hyperkinetic disorders

102

2.68

5.49

2.4

2.9

—

Persons encountering health services for other counselling and medical advice, not elsewhere classified

2.33

5.48

2.7

—

Non-selective monoamine reuptake inhibitors

12.34

5.44

2.8

2.0

—

Headache

2.99

5.41

2.0

2.5

—

Other and unspecified myopathies

16.03

5.41

2.6

5.2

—

Other diseases of the digestive system

5.18

5.38

3.9

2.0

—

GI-bleeding

5.17

5.37

3.9

2.0

—

Disorders of urea cycle metabolism

+∞

5.34

4.6

0.0

—

ILD medications: prednisolone, methylprednisolone, prednisone

2.32

5.27

2.7

2.8

—

Cerebral palsy

6.77

5.27

2.7

3.1

—

Disorders of amino-acid transport

+∞

5.27

11.6

0.0

—

Schizophrenia or delusion, excluding more controls

11.11

5.24

1.8

3.3

—

Disorders of aromatic amino-acid metabolism

+∞

5.24

16.4

0.0

—

Other diseases of intestines

135

2.10

5.22

2.8

2.6

—

All influenza (not pneumonia)

5.39

5.21

7.5

1.7

—

Visual disturbances and blindness

2.75

5.17

1.6

2.3

—

Other viral diseases, including avohilmo

137

2.39

5.15

2.9

2.6

—

Other and unspecified iron deficiency

3.46

5.14

2.2

3.2

—

Hypothyroidism (congenital or acquired)

4.42

5.11

4.5

3.3

—

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

2.87

5.10

4.5

2.4

—

Other and unspecified erythematous conditions

13.40

5.08

11.0

2.7

—

Other erythematous conditions

13.40

5.08

11.0

2.7

—

Misadventures to patients during surgical and medical care

13.35

5.07

6.0

1.0

—

Congenital malformations of the nervous system

5.72

5.07

1.8

3.7

—

Noninfectious colitis NAS

5.19

5.07

2.6

3.6

—

Nonorganic sleeping disorders, excluding more controls

8.34

5.05

1.5

2.3

—

Constipation

121

2.24

5.01

2.5

2.2

—

Other diseases of pleura

4.49

4.97

2.1

2.7

—

Bacterial infection, other or unspecified

3.12

4.97

2.4

—

Noninfective enteritis and colitis

117

2.48

4.92

3.0

2.3

—

Other strabismus

2.72

4.89

2.1

2.5

—

Dizziness and giddiness

3.21

4.82

1.6

3.0

—

Congenital malformations of the musculoskeletal system, not elsewhere classified, including avohilmo

11.54

4.79

3.4

4.0

—

Intestinal malabsorption

11.47

4.78

4.1

2.6

—

Infections, IBD-co-morbidities

5.71

4.78

3.9

3.0

—

Dialysis, with operation codes

5.21

4.76

9.3

2.3

—

Abnormalities of gait and mobility

5.72

4.74

1.1

1.4

—

L04AD Calcineurin inhibitors

3.41

4.74

4.0

2.5

—

Episodal and paroxysmal disorders

120

2.07

4.74

2.2

2.5

—

Focal epilepsy, strict definition

3.27

4.73

4.1

3.2

—

Persons encountering health services in other circumstances

2.95

4.72

2.4

—

Strabismus

102

2.54

4.67

2.1

2.3

—

Other symptoms and signs involving cognitive functions and awareness

4.77

4.66

2.7

3.0

—

Other disorders starting during childhood or adolescence

2.59

4.62

4.3

2.4

—

Special screening examination for other diseases and disorders

14.00

4.57

1.1

1.2

—

Inflammatory diseases of the central nervous system

8.20

4.56

3.0

5.0

—

Volume depletion

8.19

4.56

2.2

2.1

—

Other bacterial intestinal infections

8.19

4.55

2.1

3.4

—

Bacterial intestinal infections, IBD co-morbidities

8.19

4.55

2.1

3.4

—

Diseases of the eye and adnexa

2.27

4.54

2.4

2.6

—

Oxycodone

8.55

4.52

2.0

2.6

—

Astigmatism

4.18

4.50

1.3

3.3

—

Disorders of speech understanding and production

3.06

4.48

2.0

3.0

—

Dependence on enabling machines and devices, not elsewhere classified

6.76

4.47

6.4

1.4

—

Isolated growth hormone deficiency

4.83

4.43

6.1

2.7

—

Visual disturbances

2.82

4.37

1.6

2.1

—

Abnormal involuntary movements

7.51

4.35

1.1

2.1

—

Acute renal failure

7.51

4.35

3.7

2.3

—

Other and unspecified tonsillitis

2.66

4.34

3.7

2.1

—

Depression or dysthymia

3.64

4.32

4.2

3.6

—

Mild mental retardation

5.55

4.29

1.4

3.2

—

Cutaneous abscess, furuncle and carbuncle

3.95

4.29

2.6

2.7

—

Adrenocortical insufficiency

11.71

4.28

2.3

4.7

—

Fungal Sepsis

11.71

4.27

2.4

2.8

—

Diagnoses used for exclusion with ILD

8.89

4.27

5.6

2.1

—

Other complications of surgical and medical care, not elsewhere classified

11.68

4.27

2.4

3.0

—

Focal epilepsy

3.04

4.23

4.1

3.1

—

Hypothyroidism, other/unspecified

2.63

4.19

3.5

2.8

—

Hypothyreosis and Thyroxine purchase for inclusion criteria

2.62

4.16

3.5

2.8

—

Mood [affective] disorders

2.38

4.15

2.7

3.3

—

Mood disorders

2.38

4.13

2.7

3.3

—

Excessive, frequent and irregular menstruation

3.93

4.13

2.8

2.4

—

ILD medications: immunosuppressive drugs

109

2.33

4.12

2.9

2.7

—

Dysphagia

5.89

4.12

2.5

1.8

—

Congenital malformations of the musculoskeletal system, not elsewhere classified

10.10

4.02

3.6

4.0

—

Other coagulation defects

10.02

4.01

1.6

2.6

—

Iron deficiency anaemia secondary to blood loss (chronic)

10.01

4.01

3.6

5.4

—

Pervasive developmental disorders excl. Autism + Asperger

4.21

3.98

1.8

3.1

—

Abnormal results of function studies

6.44

3.98

1.3

2.3

—

Diseases of oesophagus, stomach and duodenum

2.25

3.97

3.5

2.1

—

Personality disorders

5.56

3.97

1.4

3.9

—

Emotional disorders and disorders of social functioning with onset specific to childhood

2.93

3.96

1.5

2.3

—

Chronic kidney disease

4.17

3.96

5.7

2.6

—

Urticaria and erythema

2.47

3.95

5.5

2.1

—

Dyspnoea

2.32

3.93

2.5

2.1

—

Other congenital malformations of the digestive system

2.81

3.90

2.3

2.7

—

ILD medications

120

1.98

3.89

2.6

2.7

—

Abnormal serum enzyme levels

4.83

3.87

4.7

2.5

—

Osteopathies and chondropathies

2.71

3.83

2.6

2.8

—

Specific personality disorders

6.00

3.81

1.4

4.5

—

Other bacterial intestinal infections, including avohilmo

6.00

3.81

2.1

3.1

—

Disorders of adult personality and behaviour

4.29

3.81

1.4

3.5

—

Other congenital malformations of brain

9.02

3.80

2.1

5.1

—

Abnormalities of breathing

102

2.07

3.78

2.2

3.0

—

Nystagmus and other irregular eye movements

8.84

3.78

1.4

4.1

—

Disturbance of activity and attention

2.47

3.76

2.7

2.4

—

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

3.70

3.75

4.1

3.5

—

Eating disorder

4.14

3.69

2.9

2.7

—

Crossbite

2.36

3.67

3.1

2.2

—

Gastro-oesophageal reflux disease

2.67

3.66

3.2

2.0

—

Follow-up examination after treatment for conditions other than malignant neoplasms

4.88

3.66

1.9

2.9

—

Symptoms and signs involving the digestive system and abdomen

100

2.00

3.63

2.7

2.2

—

Anomalies of dental arch relationship, including avohilmo

2.39

3.63

2.6

2.2

—

Extrapyramidal and movement disorders

4.40

3.61

1.4

3.2

—

Other medical care

3.17

3.60

1.6

2.3

—

Migraine

2.42

3.60

2.2

2.7

—

Asthma (only as main-diagnosis)

2.73

3.59

1.9

2.2

—

Eating disorders

4.00

3.58

2.9

—

Symptoms and signs concerning food and fluid intake

4.00

3.58

2.6

3.1

—

Other congenital malformations of intestine

7.92

3.57

3.7

3.6

—

Other congenital malformations of intestine, including avohilmo

7.88

3.57

3.7

3.6

—

Collagenous colitis

7.79

3.55

3.9

4.6

—

Provisional assignment of new diseases of uncertain etiology

2.45

3.55

2.7

2.5

—

Other eating disorders

4.77

3.55

3.3

2.1

—

Codes for special purposes

2.45

3.55

2.7

2.5

—

Bleeding

2.25

3.54

3.4

2.2

—

Asthma (only as main-diagnosis), excluding more controls

2.70

3.51

1.9

2.2

—

Other disorders of adrenal gland

6.17

3.50

2.1

3.9

—

Care involving dialysis

6.17

3.50

7.7

1.5

—

Other symptoms and signs involving the urinary system

10.01

3.49

1.5

2.8

—

Coagulation defects, purpura and other haemorrhagic conditions

3.61

3.49

3.7

2.2

—

Other degenerative diseases of the nervous system

8.51

3.48

1.9

1.3

—

Any reimbursement code in KELA

2.37

3.48

3.7

1.2

—

Retention of urine

6.47

3.47

2.1

2.2

—

Conjunctivitis

142

1.98

3.46

1.5

2.8

—

Codeine

2.96

3.46

1.4

3.2

—

Pain and other conditions associated with female genital organs and menstrual cycle

5.37

3.44

2.8

—

Viral pneumonia

4.55

3.42

7.5

2.2

—

Acute tubulo-interstitial nephritis

2.38

3.40

3.7

2.3

—

Depression

2.26

3.40

2.9

3.4

—

Disorders of conjunctiva

143

1.95

3.38

2.3

2.8

—

Other viral diseases

126

2.14

3.37

3.4

2.6

—

Irregular menses

3.09

3.37

3.0

2.5

—

Arthropod-borne viral fevers and viral haemorrhagic fevers, including avohilmo

3.10

3.36

1.7

3.0

—

Hypothyroidism, levothyroxine purchases

3.84

3.36

4.8

3.3

—

Hypothyroidism and >3 levothyroxin purchases

3.84

3.36

4.8

3.3

—

Open bite

2.93

3.30

5.6

2.8

—

Renal tubulo-interstitial diseases

106

2.07

3.28

3.5

2.2

—

Other and unspecified coagulation defects

8.59

3.26

1.7

2.6

—

Lung diseases due to external agents

8.58

3.26

3.7

5.4

—

Rash and other nonspecific skin eruption

4.74

3.23

1.1

2.9

—

Other bacterial diseases

114

1.97

3.21

3.2

2.6

—

Hypothyroidism, strict autoimmune

2.72

3.21

1.9

2.1

—

Other disorders of urethra and urinary system

2.61

3.20

2.9

2.2

—

Factors influencing health status and contact with health services

5.65

3.19

5.0

1.1

—

Haemolytic anaemias

6.39

3.18

3.4

3.3

—

Extracorporeal dialysis

6.38

3.18

7.4

2.4

—

Asthma (mode)

2.56

3.18

1.9

2.2

—

Acute suppurative otitis media

2.28

3.17

3.3

2.2

—

Bacterial infection, other or unspecified, including avohilmo

2.41

3.17

2.4

2.3

—

Other viral diseases, not elsewhere classified, including avohilmo

123

2.10

3.13

2.5

2.6

—

Use of hypnotics and sedatives

2.13

3.11

4.1

2.5

—

Substance use, excluding alcohol

4.50

3.11

2.1

4.6

—

Heterophoria

4.01

3.08

3.1

3.5

—

Covid-19 confirmed case

2.80

3.07

2.9

2.7

—

Gastrointestinal diseases

2.09

3.07

3.1

2.3

—

Asthma

2.52

3.06

1.9

2.2

—

Childhood asthma (age<16)

3.28

3.05

2.2

2.4

—

Colectomy operation

7.51

3.05

2.2

4.9

—

Other diseases of intestine

7.51

3.05

2.8

4.0

—

Bacterial pneumonia (organism specified)

2.82

3.04

1.5

2.7

—

Disorders of continuity of bone

5.84

3.02

1.3

3.2

—

Any death

3.50

3.00

2.1

2.5

—

Fitting and adjustment of other devices

5.03

3.00

1.9

2.4

—

Certain infectious and parasitic diseases

1.99

3.00

2.8

2.3

—

Nephropathy related operations

3.55

2.98

10.0

2.5

—

Implicit fungal Sepsis

10.03

2.98

1.0

3.0

—

Dystonia

10.02

2.98

1.6

7.2

—

Pneumonitis due to solids and liquids

10.01

2.98

3.6

7.2

—

Autism spe, excluding more controls

10.02

2.98

1.0

2.6

—

Symptoms and signs involving speech and voice

3.85

2.97

2.3

2.7

—

Concussion

2.20

2.97

2.6

2.4

—

Erosion of teeth , including avohilmo

2.83

2.91

2.8

2.7

—

Inflammatory bowel disease treatment related agents

114

1.85

2.89

2.1

3.0

—

Caries of dentine

3.21

2.88

3.8

1.5

—

Other and unspecified urticaria

2.69

2.88

3.0

2.4

—

Bacterial pneumoniae

2.85

2.88

1.5

2.2

—

Hypertension, essential

2.93

2.87

3.9

2.3

—

Symptoms and signs involving emotional state

6.69

2.87

1.3

4.4

—

Event of undetermined intent

6.68

2.87

1.8

5.8

—

Wide developmental disorders

2.59

2.85

1.7

2.7

—

Short stature starting before birth

4.64

2.84

1.9

2.3

—

Osteoporosis

4.59

2.83

4.4

2.2

—

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

2.78

2.82

1.8

2.6

—

Dentofacial anomalies [including malocclusion]

105

2.01

2.81

2.4

2.5

—

Cystitis

2.09

2.80

2.2

—

Oral corticosteroids

2.16

2.80

2.5

3.2

—

Other viral diseases, not elsewhere classified

2.18

2.80

2.8

—

Other extrapyramidal and movement disorders in other diseases

4.45

2.79

1.5

3.9

—

Used for control exclusion in common control thyroid runs

119

1.78

2.78

2.9

2.3

—

Disorders of skin appendages

2.33

2.77

4.2

3.0

—

Encephalitis

8.36

2.75

2.6

4.7

—

Other specified/unspecified bacterial intestinal infections

8.35

2.75

2.2

6.8

—

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

8.34

2.75

2.2

6.2

—

Other disorders of conjunctiva

8.34

2.75

6.8

2.8

—

Hypo-osmolality and hyponatraemia

8.27

2.73

6.2

3.2

—

Certain conditions originating in the perinatal period

2.13

2.70

2.8

—

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

2.25

2.70

1.4

3.0

—

Other congenital malformations of the digestive system, including avohilmo

2.30

2.70

2.3

2.7

—

First line medication for Crohn's disease

125

1.76

2.70

2.7

—

Pruritus

6.01

2.69

1.0

6.3

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

4.94

2.69

1.3

2.8

—

Abnormal weight loss

4.22

2.67

2.4

3.6

—

Symptoms and signs involving the skin and subcutaneous tissue

2.10

2.65

1.3

2.5

—

Emotional disorders starting during childhood or adolescence

2.48

2.64

1.4

2.5

—

Disorders of the thyroid gland

2.16

2.64

3.5

2.7

—

Asthma, excluding more controls

2.38

2.63

1.9

2.2

—

Acute upper respiratory infections of multiple and unspecified sites

2.06

2.63

3.4

2.4

—

Childhood asthma (age<16), excluding more controls

3.03

2.63

2.1

2.4

—

Viral haemorrhagic fevers, not elsewhere classified/unspecified, including avohilmo

2.93

2.61

1.7

3.1

—

Asthma-related pneumonia

2.38

2.60

2.2

2.5

—

Asthma, hospital admissions 3, pneumonia

2.38

2.60

2.2

2.5

—

Asthma-related pneumonia or sepsis

2.38

2.60

2.2

2.5

—

Autism

4.68

2.60

1.0

4.0

—

Visual impairment including blindness (binocular or monocular)

4.67

2.59

1.7

3.5

—

Scissor bite

2.92

2.59

1.3

4.1

—

Kidney transplant status

3.61

2.57

5.2

2.8

—

Bacterial pneumonia, not elsewhere classified

2.93

2.57

1.6

2.1

—

Weight loss

4.00

2.56

2.4

3.6

—

Other and unspecified mood [affective] disorders

7.15

2.55

1.2

4.1

—

Mixed and other personality disorders

7.15

2.55

1.0

5.4

—

Disorders of mineral metabolism

7.15

2.55

12.0

2.7

—

Enterocolitis due to Clostridium difficile

7.15

2.55

1.8

5.4

—

Other acute lower respiratory infections

128

1.93

2.55

3.1

2.4

—

Undetermined asthma

7.14

2.54

1.0

1.1

—

Undetermined asthma, excluding more controls

7.14

2.54

1.0

1.1

—

Other menopausal disorders

6.69

2.54

2.8

2.0

—

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

5.46

2.54

2.2

2.4

—

Anorexia (incl.atypical)

5.46

2.54

1.2

3.9

—

Presence of other functional implants

3.42

2.52

4.8

1.8

—

Nonsuppurative otitis media

2.14

2.51

2.6

2.1

—

Suppurative and unspecified otitis media

2.05

2.49

3.0

2.1

—

Other diseases of urinary system

1.85

2.49

2.6

2.2

—

Cough

2.12

2.49

2.4

3.0

—

Allergic conjunctivitis

2.11

2.48

1.4

3.5

—

Dermatitis and eczema

129

1.74

2.48

2.3

2.4

—

Recurrent or chronic depression

3.67

2.48

5.6

2.8

—

Myopia

3.46

2.48

3.6

4.0

—

Other disorders of eye and adnexa

3.46

2.48

1.4

3.2

—

Cardiomyopathy

4.37

2.47

1.3

2.2

—

Scoliosis

3.81

2.46

1.0

2.5

—

Depression medications

3.25

2.45

3.9

4.2

—

Haemorrhage from respiratory passages

3.16

2.42

2.1

2.4

—

Other congenital malformations

2.29

2.40

1.5

2.8

—

Unspecified privation

5.00

2.40

1.2

4.7

—

Other diseases of blood and blood-forming organs, wide

3.34

2.39

5.0

2.7

—

Congenital malformations and deformations of the musculoskeletal system, including avohilmo

2.07

2.38

2.0

2.7

—

Implicit fungal Sepsis, including avohilmo

6.26

2.37

1.0

2.4

—

Other specified and unspecified personality disorders

6.26

2.37

1.6

6.4

—

Other and unspecified polyneuropathies, also in other diseases

6.25

2.37

3.0

3.6

—

Infections of the skin and subcutaneous tissue

144

1.84

2.33

2.3

2.8

—

Nonsuppurative otitis media, including avohilmo

2.06

2.30

3.0

2.0

—

Congenital malformations and deformations of the musculoskeletal system

2.08

2.29

2.1

2.8

—

Vocal cord dysfunction

4.80

2.29

2.0

2.3

—

Birth asphyxia

3.99

2.27

1.0

2.2

—

Digestive system disorders of fetus and newborn

6.05

2.27

4.6

1.2

—

Poisoning by drugs, medicaments and biological substances

3.48

2.26

3.3

3.2

—

Hypermetropia

2.56

2.26

1.3

3.0

—

Phobic anxiety disorders

3.47

2.26

1.5

2.9

—

Syncope and collapse

2.98

2.26

1.5

2.8

—

Secondary hypertension

4.55

2.24

6.5

1.2

—

COPD/asthma related infections

1.96

2.23

3.3

2.3

—

COPD/asthma/ILD related infections

1.96

2.23

3.3

2.3

—

Diseases of the respiratory system

2.30

2.22

3.6

2.3

—

Other and unspecified drugs and medicaments

5.56

2.21

2.4

5.8

—

Cardiomyopathies, Primary/intrinsic

5.56

2.21

1.2

2.6

—

Cardiomyopathy (excluding other)

5.56

2.21

1.2

2.6

—

Oedema, not elsewhere classified

3.40

2.21

3.3

3.2

—

Substance abuse

2.53

2.20

2.7

2.9

—

Polycystic ovarian syndrome, consortium definition

2.39

2.20

2.9

2.4

—

Presence of other devices

5.47

2.18

2.4

2.8

—

Migraine without aura

2.50

2.18

2.0

2.6

—

Hypertensive diseases (excluding secondary)

2.08

2.17

3.7

1.8

—

Other arrhythmias

2.37

2.16

6.0

2.1

—

Type 2 diabetes, definitions combined, including avohilmo

2.45

2.16

4.1

2.4

—

Immunodeficiencies

4.30

2.15

1.7

4.4

—

Contraceptive management

2.91

2.15

3.1

2.2

—

Schizophrenia or delusion

3.00

2.14

1.8

3.4

—

Schizophrenia, schizotypal and delusional disorders

3.00

2.14

1.8

3.4

—

COPD differential diagnosis

2.20

2.14

3.6

2.2

—

ILD differential diagnosis

2.20

2.14

3.6

2.2

—

Excluding asthma or asthma-COPD overlap

2.20

2.14

3.6

2.2

—

Other pulmonary diagnosis

2.20

2.14

3.6

2.2

—

Diseases of arteries, arterioles and capillaries (FINNGEN)

4.60

2.13

1.5

1.0

—

Intermittent heterotropia

2.45

2.09

2.8

—

Subjective visual disturbances

3.20

2.09

1.9

3.1

—

Diseases of arteries, arterioles and capillaries

2.82

2.09

1.3

3.0

—

Other congenital malformations, including avohilmo

2.14

2.07

1.5

2.7

—

Disorders of gallbladder, biliary tract and pancreas

2.11

2.07

2.0

2.8

—

Codeine or tramadol medication

2.20

2.07

1.4

3.5

—

Simple and mucopurulent chronic bronchitis

5.01

2.07

2.2

2.9

—

Elevated blood glucose level

5.01

2.07

2.2

3.7

—

Ptosis of eyelid

5.00

2.07

1.6

4.3

—

Other sleep disorders

5.00

2.07

1.2

2.2

—

Sequelae with surgical and medical care as external cause

5.00

2.07

3.4

4.3

—

Polyuria

5.00

2.07

1.2

2.2

—

Other spirochaetal diseases

2.90

2.07

1.4

2.7

—

Nonorganic sleeping disorders

2.70

2.06

1.5

2.9

—

Hernia of abdominal wall, postoperative

4.97

2.06

3.0

1.2

—

Candidiasis

3.50

2.05

2.4

—

Sequelae of external causes of morbidity and mortality

3.50

2.05

3.3

3.1

—

Viral infections characterized by skin and mucous membrane lesions

110

1.91

2.04

3.2

2.7

—

Unspecified acute lower respiratory infection

3.08

2.01

5.4

3.0

—

Noninflammatory disorders of female genital tract

2.62

2.01

2.6

2.8

—

Otitis media, unspecified

2.06

2.00

3.3

2.2

—

Deforming dorsopathies

2.63

2.00

1.1

2.2

—

Intracranial trauma

1.87

1.98

2.6

2.4

—

Genitourinary diseases

105

1.67

1.97

4.1

2.3

—

Other and unspecified nonorganic psychotic disorders

3.33

1.96

1.1

4.0

—

Other soft tissue disorders, not elsewhere classified

129

1.63

1.95

3.6

2.2

—

Symptoms and signs involving the urinary system

1.91

1.95

3.3

2.3

—

Divergent concomitant strabismus

4.55

1.94

4.0

4.4

—

Emotionally unstable personality disorder

4.55

1.94

1.2

4.9

—

Certain infectious and parasitic diseases, including avohilmo

1.93

2.9

2.3

—

Disorders of optic nerve and visual pathways

2.97

1.93

7.6

3.4

—

Systemic connective tissue disorders

2.96

1.93

1.5

2.9

—

All kidney diseases

128

1.67

1.93

3.3

2.2

—

Other spirochaetal diseases, including avohilmo

2.73

1.93

1.4

2.6

—

Mycoses

2.73

1.93

4.8

2.3

—

Hypothyroidism, strict autoimmune, 3 medication purchases required

2.19

1.92

1.8

2.8

—

Cardiovascular diseases (excluding rheumatic etc)

131

1.62

1.90

3.2

2.7

—

Type 2 diabetes, definitions combined

2.36

1.89

4.1

2.5

—

Other bacterial diseases, including avohilmo

139

1.62

1.88

3.6

2.4

—

Varicella [chickenpox], including avohilmo

2.65

1.86

2.2

3.2

—

Acute pharyngitis

2.22

1.86

2.1

2.6

—

Mouth breathing

114

1.84

1.85

1.6

2.9

—

Non-invasive ventilation

3.18

1.84

5.1

2.2

—

Chronic diseases of tonsils and adenoids

122

1.65

1.83

2.5

2.6

—

Disorders of choroid and retina

2.27

1.83

4.5

2.7

—

Generalized epilepsy, strict definition

4.18

1.82

1.2

2.9

—

Zoster [herpes zoster]

4.17

1.82

5.2

3.8

—

Social phobias

4.17

1.82

1.2

2.7

—

Mental and behavioural disorders due to psychoactive substance use

2.29

1.81

2.7

—

Behavioural syndromes associated with physiological disturbances and physical factors

101

1.74

1.81

2.9

2.8

—

Diseases of middle ear and mastoid

111

1.77

1.81

3.8

2.1

—

Other and unspecified disorders of psychological development

2.80

1.79

1.0

3.3

—

Urticaria

1.95

1.79

2.6

2.1

—

Sleep disorders (combined)

1.72

1.77

3.9

2.7

—

Focal epilepsy, mode (most common among epilepsy diagnosis)

2.34

1.77

5.5

3.1

—

Type 2 diabetes

2.19

1.74

3.8

2.5

—

Other disorders originating in the perinatal period

2.33

1.72

1.6

2.3

—

Hypertension

1.85

1.71

3.6

2.0

—

Asthma-related infections

144

1.69

2.0

2.9

—

Asthma, hospital admission 2, infections

144

1.69

2.0

2.9

—

Tramadol

2.61

1.69

2.4

3.1

—

Symptoms and signs involving the circulatory and respiratory systems

102

1.62

1.69

3.0

—

Malnutrition

3.17

1.66

2.2

3.3

—

Type of accident

2.50

1.66

2.6

2.4

—

Endometriosis

4.15

1.66

4.8

3.4

—

Cholecystectomy

2.50

1.66

2.6

2.9

—

Irritable bowel syndrome

3.16

1.66

3.7

2.9

—

Asthma, unspecified (mode)

2.33

1.66

1.4

2.3

—

Lyme disease, including avohilmo

2.58

1.65

1.0

2.7

—

Lyme disease

2.58

1.65

1.0

2.7

—

Spirochaetal infections, other/unspecified, including avohilmo

2.58

1.65

1.0

2.7

—

Gingival hyperplasia

2.81

1.65

1.3

3.8

—

Other specified/unspecified arthritis

2.80

1.65

1.4

2.4

—

Shoulder lesions

2.50

1.64

9.0

2.5

—

Asthma, unspecified (mode), excluding more controls

2.31

1.63

1.4

2.3

—

Other disorders of kidney and ureter

3.57

1.61

3.4

—

Obsessive-compulsive disorder

3.57

1.61

1.2

3.5

—

Acute bronchitis

1.84

1.61

2.2

—

Other systemic involvement of connective tissue (FG)

3.51

1.58

1.2

3.9

—

Bronchitis

1.68

1.58

3.8

2.2

—

Disturbances of skin sensation

3.00

1.58

1.7

3.6

—

Other systemic involvement of connective tissue

3.00

1.58

1.7

3.6

—

Other disorders of optic [2nd] nerve and visual pathways

2.70

1.58

8.6

3.5

—

Invasive ventilation

2.70

1.58

2.9

2.8

—

Congenital malformations of genital organs

2.05

1.57

5.7

2.5

—

Conjunctivitis (acute, non atopic)

106

1.79

1.56

2.3

2.4

—

Intracranial injury

120

1.71

1.55

2.5

2.6

—

136

1.68

1.54

2.0

3.0

—

Cerebrovascular diseases (FINNGEN)

2.72

1.53

1.4

2.2

—

Open wound of ankle and foot

3.34

1.52

3.0

1.9

—

Acute upper respiratory infections

1.69

1.51

3.4

2.4

—

Fetus and newborn affected by maternal complications of pregnancy

0.00

1.51

0.0

2.2

—

Migraine without aura and triptan purchases

2.59

1.51

1.0

3.4

—

Hypertensive diseases

1.77

1.51

3.6

2.0

—

Voice disturbances

2.86

1.50

2.7

2.6

—

Hyperkinetic disorders (excl. ADHD)

2.48

1.49

1.2

2.3

—

Other/unspecified dorsalgia

2.56

1.49

2.1

2.7

—

Contact with and exposure to communicable diseases

127

0.39

1.48

3.0

2.9

—

Cardiovascular diseases

126

1.52

1.46

3.0

2.4

—

Abnormalities of heart beat

2.51

1.45

1.1

1.8

—

Neurological diseases, wide definition

1.76

1.45

4.2

2.6

—

Abdominal and pelvic pain

1.57

1.45

2.4

2.2

—

Agranulocytosis

3.13

1.44

2.4

3.1

—

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

3.13

1.44

1.4

3.9

—

Polyneuropathies and other disorders of the peripheral nervous system

3.13

1.44

3.0

2.5

—

Poisoning by medicine

2.73

1.43

2.3

3.2

—

Asthma and allergy

2.47

1.42

1.9

2.2

—

Angina pectoris

2.84

1.42

5.0

1.9

—

Internal derangement of knee

2.70

1.41

3.8

3.1

—

Rotator cuff syndrome

2.54

1.41

5.9

2.1

—

Allergic colitis

2.26

1.40

3.3

1.9

—

Cellulitis

2.25

1.40

2.0

2.6

—

Supplementary factors related to causes of morbidity and mortality classified elsewhere

2.17

1.39

2.6

2.5

—

Pain in limb

123

1.55

1.39

4.2

2.2

—

Diseases of the ear and mastoid process

104

1.54

1.39

3.5

2.1

—

Fracture of femur

3.00

1.37

2.4

4.3

—

Personal history of other diseases and conditions

1.88

1.37

4.6

2.2

—

Asthma and allergy, excluding more controls

2.38

1.36

1.9

2.1

—

Other disorders of lacrimal gland

2.61

1.36

1.3

3.2

—

Autoimmune diseases related-to ILD

1.75

1.36

2.0

2.4

—

All chronic kidney diseases

1.70

1.36

4.3

2.3

—

Disorders of lacrimal system

2.37

1.36

1.3

2.9

—

L04AX Other immunosuppressants

104

1.73

1.36

1.6

3.1

—

Ulcerative colitis, NAS

2.94

1.36

1.6

3.8

—

Corneal ulcer

2.94

1.36

1.4

3.8

—

Ischaemic heart disease, wide definition

2.59

1.35

5.3

1.7

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

2.52

1.33

5.5

2.1

—

Candidiasis, including avohilmo

2.14

1.33

2.8

1.8

—

Sleep disorders

1.72

1.33

2.5

2.7

—

Nerve, nerve root and plexus disorders

1.88

1.32

1.1

3.4

—

Type 2 diabetes, strict (exclude DM1)

2.05

1.32

4.3

2.4

—

Fracture of foot, except ankle

2.09

1.30

3.8

2.8

—

Deep bite

1.69

1.30

2.9

2.7

—

Other heart diseases, wide

129

1.50

1.30

3.9

2.4

—

Type 2 diabetes, wide definition

2.40

1.29

2.0

1.9

—

ILD medications: azathioprine

2.35

1.29

1.5

2.1

—

Assault

2.78

1.28

3.4

3.8

—

Generalized anxiety disorder

2.77

1.28

6.8

4.4

—

Other disorders of eyelid

2.46

1.27

1.5

2.8

—

Chromosomal abnormalities, not elsewhere classified

2.05

1.26

1.8

2.5

—

Other retinal disorders

2.07

1.26

5.3

2.6

—

Urinary track infection

1.70

1.26

2.0

2.5

—

Sleep apnoea

1.88

1.26

5.0

2.9

—

Atopic dermatitis, strict definition

135

1.59

1.25

2.4

2.8

—

Undescended testicle

2.24

1.24

8.3

2.5

—

Suicide or other Intentional self-harm

2.40

1.24

1.3

3.4

—

Ulcerative colitis

2.40

1.24

1.5

3.5

—

5-aminosalicylic acid

2.40

1.24

2.8

—

Azathioprine

2.22

1.24

1.5

2.3

—

Varicella [chickenpox]

2.64

1.21

2.8

3.8

—

Migraine with aura and triptan purchases

2.63

1.21

1.2

4.2

—

Fall on same level involving ice and snow

1.96

1.21

3.5

2.7

—

1.70

1.20

2.7

2.2

—

Other headache syndromes

2.10

1.18

2.0

2.5

—

Second line medication for Crohn's disease

109

1.65

1.17

1.6

3.0

—

Atopic dermatitis

124

1.54

1.16

2.5

—

Congenital malformations of the circulatory system

114

1.62

1.16

6.1

2.1

—

Soft tissue disorders

133

1.42

1.15

4.0

2.2

—

Generalized epilepsy

2.50

1.15

1.2

3.1

—

Toxic effects of substances chiefly nonmedicinal as to source

2.50

1.15

2.2

3.5

—

Other diseases of anus and rectum

2.49

1.14

3.8

3.7

—

Dermatitis

1.75

1.13

6.1

2.4

—

Reimbursement for rheumatic diseases

1.79

1.12

1.5

2.8

—

Other and unspecified effects of external causes

1.75

1.12

1.9

2.5

—

Certain disorders involving the immune mechanism

2.33

1.12

1.6

3.1

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

2.33

1.12

1.3

3.3

—

Chronic sinusitis

2.33

1.12

4.1

2.9

—

Amblyopia ex anopsia

2.00

1.12

1.3

2.6

—

Triptan medication for migraine, min. 3 purchases

1.87

1.11

1.7

3.3

—

Crowding of teeth, including avohilmo

1.61

1.10

1.9

2.5

—

Tooth eruption problems

1.70

1.10

1.3

3.2

—

Pain in throat and chest

1.63

1.10

4.2

3.3

—

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

155

1.46

1.10

2.8

2.6

—

Cardiac murmurs and other cardiac sounds

1.83

1.09

1.4

2.8

—

Tonsillectomy and adenotomy

144

1.45

1.09

2.0

2.5

—

Convergent concomitant strabismus

2.38

1.09

1.0

4.2

—

Other specified congenital malformation syndromes affecting multiple systems

2.20

1.08

1.9

2.9

—

1.54

1.08

3.8

2.2

—

Other arthritis (FG)

2.19

1.08

1.4

2.6

—

Other general symptoms and signs

2.17

1.07

1.1

3.2

—

Allergic asthma (mode)

2.13

1.06

1.9

2.2

—

Asthma, hospital admissions , main diagnosis only

161

1.46

1.05

1.9

2.8

—

Coeliac disease

2.12

1.05

1.4

2.8

—

Zoster [herpes zoster], including avohilmo

2.11

1.05

4.0

2.8

—

Redundant prepuce, phimosis and paraphimosis

2.09

1.04

8.7

2.5

—

Other congenital malformations of skin

2.28

1.03

1.0

2.7

—

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Amino acids [Identifier] in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS